89zr dfo-mstp2109a
mAbexperimentalImaging agent
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2013 (NCT01774071)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Metalloreductase STEAP1Radiopharmaceutical
STEAP1 radiopharmaceutical
Chemistry & pharmacology
- Multi-specific
- No
- Imaging
- 89-Zirconium
Oral
No
Parenteral
No
Topical
No
Also known as
- 89zr dfo-mstp2109a
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01774071 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2013 | Cornell University, Genentech |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cornell University | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Genentech | For profit | 1 | 0 | 1 | 2013 |
2 organizations
Page 1 / 1